Trisalus Life Sciences Stock Performance
| TLSIW Stock | 1.25 0.15 10.71% |
On a scale of 0 to 100, TriSalus Life holds a performance score of 6. The entity has a beta of 0.11, which indicates not very significant fluctuations relative to the market. As returns on the market increase, TriSalus Life's returns are expected to increase less than the market. However, during the bear market, the loss of holding TriSalus Life is expected to be smaller as well. Please check TriSalus Life's maximum drawdown, as well as the relationship between the skewness and price action indicator , to make a quick decision on whether TriSalus Life's existing price patterns will revert.
Risk-Adjusted Performance
Modest
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in TriSalus Life Sciences are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of fairly uncertain forward indicators, TriSalus Life showed solid returns over the last few months and may actually be approaching a breakup point. ...more
1 | Trisalus life sciences CFO buys shares worth 129,600 - Investing.com | 01/29/2025 |
2 | Trisalus Life Sciences CFO buys 33,900 in common stock - MSN | 02/05/2025 |
3 | 3 Stocks With Robust Growth Outlooks Insiders Are Buying - The Globe and Mail | 02/19/2025 |
4 | Can This Revolutionary Liver Cancer Treatment Double Drug Effectiveness New Study Shows Remarkable Results - StockTitan | 03/06/2025 |
| Begin Period Cash Flow | 9.7 M |
TriSalus |
TriSalus Life Relative Risk vs. Return Landscape
If you would invest 98.00 in TriSalus Life Sciences on December 17, 2024 and sell it today you would earn a total of 27.00 from holding TriSalus Life Sciences or generate 27.55% return on investment over 90 days. TriSalus Life Sciences is currently producing 0.7827% returns and takes up 8.9437% volatility of returns over 90 trading days. Put another way, 79% of traded stocks are less volatile than TriSalus, and 85% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
TriSalus Life Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for TriSalus Life's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as TriSalus Life Sciences, and traders can use it to determine the average amount a TriSalus Life's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0875
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | TLSIW | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 8.94 actual daily | 79 79% of assets are less volatile |
Expected Return
| 0.78 actual daily | 15 85% of assets have higher returns |
Risk-Adjusted Return
| 0.09 actual daily | 6 94% of assets perform better |
Based on monthly moving average TriSalus Life is performing at about 6% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of TriSalus Life by adding it to a well-diversified portfolio.
TriSalus Life Fundamentals Growth
TriSalus Stock prices reflect investors' perceptions of the future prospects and financial health of TriSalus Life, and TriSalus Life fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on TriSalus Stock performance.
| Return On Asset | -0.92 | ||||
| Profit Margin | (2.05) % | ||||
| Operating Margin | (0.95) % | ||||
| Revenue | 18.51 M | ||||
| Gross Profit | 23.42 M | ||||
| EBITDA | (44.33 M) | ||||
| Net Income | (59.04 M) | ||||
| Total Debt | 51.66 M | ||||
| Book Value Per Share | (0.67) X | ||||
| Cash Flow From Operations | (50.05 M) | ||||
| Total Asset | 25.73 M | ||||
| Retained Earnings | (248.38 M) | ||||
About TriSalus Life Performance
Evaluating TriSalus Life's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if TriSalus Life has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if TriSalus Life has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
TriSalus Life is entity of United States. It is traded as Stock on NASDAQ exchange.Things to note about TriSalus Life Sciences performance evaluation
Checking the ongoing alerts about TriSalus Life for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for TriSalus Life Sciences help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| TriSalus Life is way too risky over 90 days horizon | |
| TriSalus Life may become a speculative penny stock | |
| TriSalus Life appears to be risky and price may revert if volatility continues | |
| TriSalus Life has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 18.51 M. Net Loss for the year was (59.04 M) with profit before overhead, payroll, taxes, and interest of 23.42 M. | |
| TriSalus Life generates negative cash flow from operations | |
| TriSalus Life has a very weak financial position based on the latest SEC disclosures | |
| Latest headline from news.google.com: Can This Revolutionary Liver Cancer Treatment Double Drug Effectiveness New Study Shows Remarkable Results - StockTitan |
- Analyzing TriSalus Life's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether TriSalus Life's stock is overvalued or undervalued compared to its peers.
- Examining TriSalus Life's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating TriSalus Life's management team can have a significant impact on its success or failure. Reviewing the track record and experience of TriSalus Life's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of TriSalus Life's stock. These opinions can provide insight into TriSalus Life's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for TriSalus Stock Analysis
When running TriSalus Life's price analysis, check to measure TriSalus Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy TriSalus Life is operating at the current time. Most of TriSalus Life's value examination focuses on studying past and present price action to predict the probability of TriSalus Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move TriSalus Life's price. Additionally, you may evaluate how the addition of TriSalus Life to your portfolios can decrease your overall portfolio volatility.